Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 284,924 | 315,917 | 294,354 | 249,667 | 227,589 |
| Cost of Goods | N/A | 68,155 | 51,980 | 10,172 | 0 |
| Gross Profit | 284,924 | 247,762 | 242,374 | 239,495 | 227,589 |
| Operating Expenses | 134,868 | 149,466 | 190,068 | 172,227 | 124,035 |
| Operating Income | 150,056 | 98,451 | 53,286 | 67,440 | 103,554 |
| Interest Expense | 62,573 | 41,815 | 42,754 | 36,271 | 35,592 |
| Other Income | -677 | -765 | -654 | -182 | -773 |
| Pre-tax Income | 86,806 | 55,871 | 9,878 | 30,987 | 67,189 |
| Income Tax | 5,089 | -6,694 | 3,844 | 4,252 | 7,191 |
| Net Income Continuous | 81,717 | 62,565 | 6,034 | 26,735 | 59,998 |
| Net Income Discontinuous | -3,121 | 9,495 | N/A | N/A | N/A |
| Minority Interests | N/A | N/A | 37 | 134 | 111 |
| Net Income | $78,596 | $72,060 | $5,997 | $26,601 | $59,887 |
| EPS Basic Total Ops | 3.76 | 3.74 | 0.31 | 1.28 | 2.89 |
| EPS Basic Continuous Ops | 3.92 | 3.25 | 0.31 | 1.29 | 2.89 |
| EPS Basic Discontinuous Ops | -0.16 | 0.49 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 3.71 | 3.68 | 0.31 | 1.27 | 2.83 |
| EPS Diluted Continuous Ops | 3.86 | 3.19 | 0.31 | 1.27 | 2.84 |
| EPS Diluted Discontinuous Ops | -0.15 | 0.49 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 3.64 | 2.87 | 0.46 | 2.40 | N/A |
| EBITDA(a) | $260,874 | $203,111 | $162,940 | $184,618 | $185,940 |